Polychlorinated biphenyl (PCB) induction of CYP3A4 enzyme activity in healthy Faroese adults

被引:21
|
作者
Petersen, Maria Skaalum
Halling, Jonrit
Damkier, Per
Nielsen, Flemming
Grandjean, Philippe
Weihe, Pal
Brosen, Kim
机构
[1] Univ So Denmark, Inst Publ Hlth Environm Med, DK-5000 Odense C, Denmark
[2] Univ So Denmark, Inst Publ Hlth Clin Pharmacol, DK-5000 Odense C, Denmark
[3] Odense Univ Hosp, Dept Biochem Pharmacol & Genet, DK-5000 Odense, Denmark
[4] Faroese Hosp Syst, Dept Occupat & Publ Hlth, FR-100 Torshavn, Faroe Islands, Denmark
[5] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA
关键词
CYP3A4; 6 beta-hydroxycortisol/cortisol ratio; polychlorinated biphenyls; persistent organohalogen pollutants; Faroe islands;
D O I
10.1016/j.taap.2007.07.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The CYP3A4 enzyme is, along with other cytochrome P450 enzymes, involved in the metabolism of environmental pollutants and is highly inducible by these substances. A commercial polychlorinated biphenyl (PCB) mixture, 1,1,1,-trichloro-2-(o-chlorophenyl), 2-(p'-chlorophenyl) ethane (o,p'-DDT) and 1,1,-dichloro-2,2-bis (p-chlorophenyl)ethene (p,p'-DDE) are known to induce CYP3A4 activity through activation of nuclear receptors, such as the pregnane X receptor. However, this induction of CYP3A4 has not yet been investigated in humans. Thus, the aim of the study was to determine the variability of the CYP3A4 phenotype in regard to increased concentrations of PCBs and other persistent organohalogen pollutants (POPs) in healthy Faroese adults. In 3 10 randomly selected Faroese residents aged 18-60 years, the CYP3A4 activity was determined based on the urinary 6 beta-hydroxycortisol/cortisol (6 beta-OHC/FC) ratio. POP exposures were assessed by measuring their concentrations in serum lipid. The results showed a unimodal distribution of the 6 beta-OHC/FC ratio with values ranging from 0.58 to 27.38. Women had a slightly higher 6 beta-OHC/ FC ratio than men (p=0.07). Confounder-adjusted multiple regression analysis showed significant associations between 6 beta-OHC/FC ratios and Sigma PCB, PCB-TEQ and p,p'-DDE, o,p'-DDT and HCB, respectively, but the associations were statistically significant for men only. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 50 条
  • [21] Effect of CYP3A4 induction and inhibition on the pharmacokinetics of SHR0302 in healthy subjects
    Zhang, Zhe
    Gao, Xuehu
    Zhang, Ping
    Li, Yuan
    Fu, Meng
    Lin, Hongda
    Feng, Sheng
    Shen, Kai
    Yu, Guoning
    Li, Xin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (08) : 2561 - 2568
  • [22] A DDI STUDY TO EVALUATE THE CYP3A4 INDUCTION POTENTIAL OF BELZUTIFAN IN HEALTHY PARTICIPANTS.
    Kauh, E.
    Bondiskey, P.
    Marathe, D.
    Ellison, M.
    Bateman, T.
    Shaw, P.
    Lai, E.
    Stoch, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S26 - S27
  • [23] Expression of CYP3A4 mRNA is correlated with CYP3A4 protein level and metabolic activity in human liver
    Watanabe, M
    Kumai, T
    Matsumoto, N
    Tanaka, M
    Suzuki, S
    Satoh, T
    Kobayashi, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 (04) : 459 - 462
  • [24] PREDNISONE DOES NOT LEAD TO A SIGNIFICANT INDUCTION OF CYP3A4
    Marcantonio, E. E.
    Hreniuk, D.
    Ding, Y.
    Zajic, S.
    Stone, J.
    Wagner, J. A.
    Stoch, S. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S27 - S27
  • [25] Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity
    Westlind-Johnsson, A
    Hermann, R
    Huennemeyer, A
    Hauns, B
    Lahu, G
    Nassr, N
    Zech, K
    Ingelman-Sundberg, M
    von Richter, O
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (04) : 339 - 349
  • [26] Evaluation of CYP3A4 induction and inhibition on regorafenib and its major circulating metabolites in healthy subjects
    Gerisch, M.
    Lettieri, J. T.
    Boix, O.
    Lin, T.
    Diefenbach, K.
    Hafner, F. T.
    Radtke, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 289 - 289
  • [27] Effect of influenza immunization on CYP3A4 activity
    Hayney, MS
    Hammes, RJ
    Fine, JP
    Bianco, JA
    VACCINE, 2001, 20 (5-6) : 858 - 861
  • [28] Effect of NIPRISANA® on CYP3A4 activity in vitro
    Adzu, Bulus
    Masimirembwa, Collen
    Mustapha, Kudirat Bola
    Thelingwani, Roslyn
    Kirim, Rukaiyatu Abdullahi
    Gamaniel, Karniyus Shingu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2015, 40 (01) : 115 - 118
  • [29] Effects of metronidazole on hepatic CYP3A4 activity
    Haas, CE
    Kaufman, DC
    DiCenzo, RC
    PHARMACOTHERAPY, 2001, 21 (10): : 1192 - 1195
  • [30] Characterization of the modulation of the CYP3A4 activity by Efavirenz
    Hariparsad, N
    Nallani, SC
    Desai, PB
    DRUG METABOLISM REVIEWS, 2003, 35 : 79 - 79